Clinical Trial Update: Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the immunologic impact of dupilumab in patients with asthma and chronic rhinosinusitis with nasal polyps; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Dr. Andrew Thamboo, MD | Conditions: Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | Status: NOT_YET_RECRUITING